Palmitoyl Tetrapeptide-7 | Anti-Inflammatory Signal Peptide for Sensitive Skin
A solvent-free powder with ≥98.0% HPLC purity, peptide content ≥85.0% and a direct chloride specification of ≤8.0%. CAS 221227-05-0 (INCI: PALMITOYL TETRAPEPTIDE-7). Used at 0.01%–0.1%, it calms IL-6-driven skin micro-inflammation and supports barrier repair.

Palmitoyl Tetrapeptide-7
A classic anti-inflammatory and repairing signal peptide that helps regulate skin micro-inflammation and improve barrier homeostasis, suitable for sensitive-skin anti-aging and inflammation-repair needs.
Plamed supplies a high-activity pure powder grade of Palmitoyl Tetrapeptide-7, with an international total-chlorine quality control system delivering higher purity, better formulation compatibility and consistent quality.
At a glance
Item | Detail |
Product | Palmitoyl Tetrapeptide-7 (anti-inflammatory signal peptide) |
Product ID | PMKZ2901 |
INCI name | PALMITOYL TETRAPEPTIDE-7 |
Other names | Tetrapeptide-7; palmitoyl tetrapeptide; anti-inflammatory tetrapeptide |
CAS number | 221227-05-0 |
Molecular formula | C₃₄H₆₂N₈O₇ |
Molecular weight | 694.8 g/mol |
Purity | ≥98.0% (HPLC); measured up to 98.8% |
Measured peptide content | Internal control ≥85.0%; batch measured up to 94.0% |
Chloride content | ≤8.0% (specification); measured 3.7% |
Appearance | White to off-white powder |
Solubility | Soluble in ethanol/1,3-propanediol (EtOH/PDO) system |
Reference dosage | 0.01%–0.1% |
Minimal package | 10 g bottle |
MOQ | 10 g |
Storage | Sealed, 2–8 °C (no −20 °C cold chain required) |

In short: Palmitoyl Tetrapeptide-7 (INCI: PALMITOYL TETRAPEPTIDE-7; CAS 221227-05-0; Product ID PMKZ2901) is a widely formulated anti-inflammatory and repairing signal peptide in premium skincare. Also known as Tetrapeptide-7, it is a benchmark active for sensitive-skin anti-aging and anti-inflammatory repair of acne-prone skin, used at 0.01%–0.1%.
What it does. It targets the excessive release of inflammatory mediators — notably the pro-inflammatory cytokine IL-6 — cutting off chronic skin micro-inflammation signaling and inhibiting MMP overexpression. At the same time it promotes fibroblast synthesis of type I/III collagen, fibronectin and glycosaminoglycans, acting as an anti-inflammatory stabilizer for the skin microenvironment. It also improves skin microcirculation and reduces vascular permeability and tissue fluid exudation.
How it is made. Plamed manufactures cosmetic-grade Palmitoyl Tetrapeptide-7 by solid-phase peptide synthesis (SPPS), producing a highly active pure powder with HPLC purity ≥98.0% and an internal control for active peptide content of ≥85.0% (batch measured values reach 94.0%).
The differentiated quality metric: total chlorine content. Plamed defines purity and formula compatibility by directly measuring total chloride ion residues — accurate, unambiguous data on non-active ion residues, in line with USP/EP pharmacopoeia testing logic. The measured chlorine content of this product is 3.7%, far below the ≤8.0% internal control, filling a quality-control blind spot left by the industry's conventional volatile-acid index.
Storage advantage. The product stores at 2–8 °C with no −20 °C ultra-low-temperature cold chain, reducing warehousing and transportation costs.
Where it fits. Core benefits cover anti-inflammation & soothing, anti-aging & wrinkle reduction, barrier strengthening and photoaging repair — widely used in sensitive-skin repair, high-end anti-aging and anti-inflammatory repair cosmetics targeting redness, fine lines, sagging and damaged barrier.
How is palmitoyl tetrapeptide-7 made? SPPS versus LPPS
Conclusion first: Palmitoyl Tetrapeptide-7 is produced by chemical peptide synthesis, and Plamed's optimized SPPS route maximizes active peptide content while minimizing chlorine and moisture impurities.
Chemical peptide synthesis has two main routes — solid-phase peptide synthesis (SPPS) and liquid-phase peptide synthesis (LPPS). Plamed has achieved breakthroughs in international total-chlorine quality control, high purity, high active peptide content and ultra-low impurity residues, meeting the compliance, efficacy and global promotion requirements of high-end cosmetic ingredients.
SPPS vs LPPS at a glance
| Solid-phase peptide synthesis (SPPS) | Liquid-phase peptide synthesis (LPPS) |
Process | Raw materials — Synthesis — Purification — Drying — Packaging | Pure liquid-phase reaction system; multi-step amino acid coupling, deprotection, stepwise extraction and purification, then freeze-drying refinement |
Advantages | High actual active content: HPLC purity ≥98%, peptide content internal control ≥85%, measured up to 94%; low moisture and chlorine impurities for greater stability; fully controlled process yielding a solvent-free powder with no solvent dilution | Low raw-material cost; high flexibility for small-batch custom synthesis; suited to short peptides and small-molecule fragments |
Limitations | Higher synthesis cost than liquid-phase; technically demanding | Complex synthesis; difficult purity control; high scale-up cost |
How to read this table: for a short anti-inflammatory peptide, the decisive buying factors are actual peptide content, chloride residue and batch consistency. Plamed's SPPS route controls all three, released against one published specification with a batch COA per lot.
What are palmitoyl tetrapeptide-7's specifications?
TEST ITEMS | SPECIFICATION |
Purity & content |
|
Purity | ≥98.0% HPLC |
Peptide content | ≥85.0% HPLC |
Chloride content | ≤8.0% |
Organoleptic |
|
Appearance | Powder |
Color | White to off-white |
Odor | Characteristic |
Physical characteristics |
|
Water content | ≤8.0% |
Heavy metals |
|
Pb | ≤10 ppm |
As | ≤2 ppm |
Hg | ≤1 ppm |
Cd | ≤5 ppm |
Microbiological |
|
Total plate count | ≤1000 cfu/g |
Yeast & mold count | ≤100 cfu/g |
How to read this specification. Three numbers matter most:
Purity ≥98.0% (HPLC) — chemical identity of the peptide fraction; Plamed batch measured values reach 98.8%.
Peptide content ≥85.0% (HPLC) — whole-sample share of active peptide; batch measured values reach 94.0%, above the release specification.
Chloride content ≤8.0% — the differentiated metric. Chloride ions are non-active residues from peptide salt formation; Plamed measures the actual residual amount directly (measured 3.7%) instead of relying on the industry's converted volatile-acid index, giving formulators unambiguous compatibility data in line with USP/EP pharmacopoeia testing logic.
A batch-specific COA is provided with every order.
Plamed produces palmitoyl tetrapeptide-7 powder through a controlled four-stage SPPS process:
1. Raw material — protected amino acid building blocks and palmitic acid derivatives released against incoming specifications.
2. Synthesis — stepwise peptide coupling builds the tetrapeptide sequence; the palmitoyl group is attached under controlled conditions.
3. Purification — combined purification removes uncoupled fragments and process-related impurities; purity, peptide content and chloride residue are verified by HPLC and ion testing.
4. Drying & product release — lyophilization yields a solvent-free white-to-off-white powder, packed in sealed pharmaceutical bottles and released only after COA verification of purity, peptide content, chloride, heavy metals and microbiological limits.
What does palmitoyl tetrapeptide-7 do for sensitive skin?
Anti-inflammation and soothing: calms micro-inflammation at the source
In short: palmitoyl tetrapeptide-7 blocks inflammatory signaling before it cascades. Studies show it effectively inhibits the overexpression and release of core pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α), cutting off the cascade amplification of inflammatory signals. It also inhibits mast cell degranulation and reduces histamine release, lowering skin hypersensitivity and quickly relieving redness, stinging and dry itching — a rare peptide raw material with dual anti-inflammatory and anti-aging effects.

Anti-aging and wrinkle reduction: "reduce loss + increase production"
The root cause it addresses: chronic inflammation continuously degrades collagen. Palmitoyl tetrapeptide-7 achieves root-cause anti-aging through two pathways. First, it inhibits overexpression of matrix metalloproteinases (MMP-1, MMP-3) — the enzymes that decompose collagen and elastic fibers — reducing the loss of skin support structures at the source. Second, it creates a microenvironment favorable to dermal regeneration: promoting fibroblast proliferation and upregulating type I/III collagen, fibronectin and glycosaminoglycan (e.g. hyaluronic acid) synthesis, increasing dermal thickness.
Synergy with Palmitoyl Tripeptide-1: build & protect
Combined with Palmitoyl Tripeptide-1 — the collagen-building signal peptide — the pair delivers a "one increase, one decrease" synergy: tripeptide-1 builds new collagen while tetrapeptide-7 protects existing collagen from inflammation-driven degradation, helping fill fine lines, improve sagging, and enhance firmness and elasticity.

Barrier repair: strengthens the "brick and mortar" structure
Cell experiments show it promotes healthy keratinocyte differentiation and upregulates key stratum-corneum structural proteins — filaggrin and loricrin. These proteins form the skin's brick-and-mortar structure; increasing them directly strengthens the physical barrier, which shows up in clinical evaluations as significantly reduced transepidermal water loss (TEWL) and improved resistance to external stimuli — meeting damaged-barrier repair needs.
Why formulators shortlist it:
As a dual anti-inflammatory and anti-aging peptide, palmitoyl tetrapeptide-7 is a common backbone of sensitive-skin anti-aging serums and is frequently listed among proven anti-aging ingredients to look for in barrier-repair moisturizers, firming eye creams and post-procedure care. At 0.01–0.1% it layers well with palmitoyl tripeptide-1, ceramides, niacinamide and soothing botanicals.
Palmitoyl Tetrapeptide-7 achieves significant anti-inflammatory and repair effects at low dosage, and is widely used across skincare formats — sensitive-skin repair serums and creams, high-end anti-aging and wrinkle-reduction products, eye essences and eye creams, post-aesthetic-treatment care, anti-photoaging sunscreens and serums, and moisturizing soothing masks and essences.
Application scenarios
Product type | Positioning with Palmitoyl Tetrapeptide-7 |
Sensitive-skin repair serums & creams | Anti-inflammatory signal peptide backbone; targets recurrent redness and sensitivity |
High-end anti-wrinkle products | "Reduce loss + increase production" anti-aging; pairs with palmitoyl tripeptide-1 |
Eye essences & eye creams | Calms and firms thin, wrinkle-prone eye-area skin |
Post-procedure care | Stabilizes micro-inflammation while barrier recovers |
Anti-photoaging sunscreens & serums | Adjunct against UV-triggered inflammatory degradation |
Soothing masks & essences | Combines calming with barrier strengthening |
Reference dosage & handling notes
Product and specification | Reference dosage |
Palmitoyl Tetrapeptide-7 (purity ≥98.0%) | 0.01%–0.1% |
Notes:
Not recommended for use with strong acids, strong bases, strong oxidizing agents, acyl chlorides or acid anhydrides.
Unopened material: store sealed at 2–8 °C (no −20 °C storage needed). After opening, use up as soon as possible to avoid moisture absorption and microbial contamination.
Recommended in combination with Palmitoyl Tripeptide-1 for "one increase, one decrease" synergistic anti-aging.
Add to cosmetic formulations below 45 °C, at the final stage of formulation.
Is palmitoyl tetrapeptide-7 safe? Regulatory status and tolerance
In China, Palmitoyl Tetrapeptide-7 is included in the IECIC — the List of Cosmetic Ingredients in Use in China (2021 Edition) administered by the National Medical Products Administration (NMPA).
In the United States, it is a recognized cosmetic ingredient listed by the Personal Care Products Council (PCPC, formerly CTFA). In the European Union, it can be notified through the Cosmetic Products Notification Portal (CPNP) under Cosmetic Regulation (EC) No 1223/2009.
Based on existing public data and application history, Palmitoyl Tetrapeptide-7 generally shows good skin tolerance under recommended use conditions: skin irritation and sensitization evaluations indicate low irritation and sensitization potential, with no obvious phototoxicity risk. No significant adverse reactions have been observed within the conventional cosmetic use concentration range (0.01%–0.1%).
Which ingredients combine with palmitoyl tetrapeptide-7?
The standard pairing is "one build, one protect": palmitoyl tetrapeptide-7 calms micro-inflammation while palmitoyl tripeptide-1 drives collagen synthesis. For barrier-repair lines it is combined with ceramides, panthenol and ectoin; for acne-prone skin it is combined with niacinamide rather than with strong acids.
How much does palmitoyl tetrapeptide-7 cost, and what is the MOQ?
Supply, packaging and samples
Item | Detail |
Product | Palmitoyl Tetrapeptide-7 |
Product ID | PMKZ2901 |
INCI name | PALMITOYL TETRAPEPTIDE-7 |
Specification | Purity ≥98.0% (HPLC, measured up to 98.8%); peptide content internal control ≥85.0% (measured up to 94.0%); chloride ≤8.0% (measured 3.7%) |
Form / solubility | Solvent-free powder; soluble in the EtOH/PDO system; add below 45 °C |
Reference dosage | 0.01%–0.1% |
Minimal package | 10 g pharmaceutical bottle with built-in sterile aluminium-foil seal |
MOQ | 10 g |
Samples | Complimentary samples for laboratory evaluation and pilot trials |
Lead time | 3–5 working days after payment for standard items |
Storage | Sealed, 2–8 °C; no −20 °C ultra-low-temperature cold chain; use up soon after opening |

What Palmitoyl Tetrapeptide-7 Offers
International total-chlorine quality control system — replaces the industry's conventional volatile-acid index with a direct ion index, redefining purity and empowering formulation decisions.
Total chlorine detection — detects all chlorine-containing compounds with no risk of missed detection.
Objective, transparent data — provides the actual chloride residual amount (3.7%) instead of converted values.
Solvent-free powder — supplied undiluted (no solvent carrier), flexible for formulation and cost-effective, with no solvent interference.
High purity and high active content — HPLC purity ≥98.0% (batch tested to 98.8%); peptide content internal control ≥85.0% (batch tested to 94.0%). The values for your lot are stated on the COA.
Low impurities, higher stability — stricter impurity control, degradation-resistant, supporting long-term stability of finished formulas.
Batch-released quality — purity, peptide content, chloride, heavy metals and microbiology released against one published specification, with a COA per lot.
Available Document of Palmitoyl Tetrapeptide-7
Certificate of Analysis (COA)
Material Safety Data Sheet (MSDS)
Composition Statement
Certificate copies: ISO 9001:2015
Halal certification
Regulatory support dossier (EU / US MoCRA / MFDS)
To request a quote or a sample, contact Plamed Green Science Group here.
Palmitoyl Tetrapeptide-7 Manufacturer and Wholesale Supplier
Plamed is a peptide manufacturer and cosmetic peptide supplier producing palmitoyl tetrapeptide-7 powder (≥98% HPLC) for sensitive-skin anti-aging, barrier-repair and anti-inflammatory formulation. For brands, distributors and ingredient buyers evaluating palmitoyl tetrapeptide-7 manufacturers and supply options, Plamed provides lab-evaluation samples, batch COAs with chloride data, and formulation support — MOQ from 10 g for R&D trials, scalable volumes for production.
Palmitoyl Tetrapeptide-7 Pricing and Wholesale Supply
Palmitoyl tetrapeptide-7 powder price depends on order volume, purity and chloride specifications, packaging and the documentation required for the destination market. Whether you are sourcing one trial batch or establishing long-term wholesale supply, contact our sales team for a quotation matched to your volume and market. The global cosmetic peptide market continues to expand, and sourcing directly from the manufacturer is the most cost-efficient route for premium anti-aging lines.
Why Source Palmitoyl Tetrapeptide-7 from Plamed?
Plamed's Palmitoyl Tetrapeptide-7 features ≥98.0% purity (HPLC), peptide content measured up to 94.0%, and a differentiated total-chlorine QC system with measured chloride of 3.7% — transparent data conventional testing cannot provide. Batch-specific COA documentation supports regulatory filing and compatibility-driven formulation work. As the manufacturer, we control SPPS synthesis, purification and release testing in-house, ensuring consistent quality from sample to bulk supply.
Q1: What is Palmitoyl Tetrapeptide-7?
A: Palmitoyl Tetrapeptide-7 (CAS 221227-05-0, INCI: PALMITOYL TETRAPEPTIDE-7) is an anti-inflammatory signal peptide — palmitic acid linked to a four-amino-acid sequence. It is the most widely used anti-inflammatory and repairing peptide in high-end cosmetics, working mainly by inhibiting pro-inflammatory cytokines such as IL-6 and TNF-α.
Q2: Is Palmitoyl Tetrapeptide-7 part of Matrixyl 3000?
A: Yes — the Matrixyl 3000® trademark (Sederma) refers to a blend of two INCI peptides: Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7. "Matrixyl 3000" is a third-party trademark; Plamed supplies the INCI ingredient itself (PMKZ2901), so formulators can build the same peptide-pair synergy with full control over purity, dosage and cost.
Q3: What are the skin benefits of Palmitoyl Tetrapeptide-7?
A: Its documented skin benefits: inhibiting IL-6/TNF-α release to calm micro-inflammation and redness; inhibiting MMP-1/MMP-3 to reduce collagen degradation; promoting fibroblast synthesis of type I/III collagen, fibronectin and glycosaminoglycans; upregulating filaggrin and loricrin to strengthen the barrier and reduce TEWL. In short: anti-inflammation, anti-aging and barrier repair in one peptide.
Q4: Is Palmitoyl Tetrapeptide-7 safe?
A: Based on public data and long application history, it shows good skin tolerance at recommended use levels (0.01%–0.1%): irritation and sensitization evaluations indicate low potential, with no obvious phototoxicity risk and no significant adverse reaction reports in conventional cosmetic use.
Q5: What form does Plamed's Palmitoyl Tetrapeptide-7 come in, and how soluble is it?
A: A solvent-free powder — no solvent dilution. It is soluble in the EtOH/PDO (ethanol / 1,3-propanediol) system and is added to formulations below 45 °C, preferably at the final stage. For solvent compatibility details, request our TDS.
Q6: What is "total chlorine quality control" and why does it matter?
A: Peptide raw materials inevitably contain chloride ion residues from salt formation. Conventional testing uses a converted volatile-acid index; Plamed directly measures total chloride residues, in line with USP/EP pharmacopoeia testing logic. This product's measured chloride is 3.7% against an internal control of ≤8.0% — objective, unambiguous data that helps formulators predict formula compatibility accurately.
Q7: What is the recommended dosage in skin care and cosmetics?
A: The reference dosage is 0.01%–0.1% for Palmitoyl Tetrapeptide-7 with purity ≥98.0%. Avoid direct combination of the raw material with strong acids, strong bases, strong oxidizing agents, acyl chlorides or acid anhydrides; adding it together with Palmitoyl Tripeptide-1 is recommended for synergistic anti-aging.
Q8: What is the MOQ? Can we get samples first?
A: Yes — the MOQ is 10 g, with complimentary samples for laboratory evaluation and pilot trials before production volumes. Standard lead time is 3–5 working days after payment.
Q9: Which documents do you provide with the product?
A: Each order comes with a batch-specific COA (including purity, peptide content and chloride data). We also provide TDS, MSDS, Composition Statement, ISO 9001:2015 and Halal certificate copies, and a regulatory support dossier (EU / US MoCRA / MFDS).
Q10: Which product types is it suitable for?
A: Sensitive-skin repair serums and creams, high-end anti-wrinkle products, eye essences and eye creams, post-procedure care, anti-photoaging sunscreens and serums, and soothing moisturizing masks — anywhere an anti-inflammatory signal peptide supports sensitive-skin anti-aging positioning.